Go Back
Onconova Therapeutics, Inc. reports $5.8 million Q1 loss
By USInMinutes - May 16, 2023, 12:05 PM ET
Last Updated - Jul 18, 2023, 03:25 PM EDT
The company generated $0.56 million in quarterly revenue
Onconova Therapeutics, Inc. [ONTX] has reported fiscal Q1 loss of $5.80 million.
On a per-share basis, the DE based company said its diluted earnings are $0.28.
The Pharmaceutical Preparations firm posted revenue of $0.56 million in this period.
Also Read:
- Onconova Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
- Onconova Therapeutics to Participate in Ladenburg Thalmann Virtual R&D Showcase on ...
- Onconova Therapeutics Doses First Patient in Phase 1/2a Trial of Narazaciclib Combined with ...
- Onconova Therapeutics to Present at the ISID International Epidermolysis Bullosa Symposium
- Onconova Therapeutics and Pangea Biomed Enter into Research Collaboration to Identify ...
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News